Cargando…
PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429708/ http://dx.doi.org/10.1097/01.HS9.0000852048.36167.63 |
| _version_ | 1784779542925148160 |
|---|---|
| author | Knoebl, P. de Haard, H. Parys, W. Ulrichts, P. Rocca, F. Guglietta, A. Ayguasanosa, J. |
| author_facet | Knoebl, P. de Haard, H. Parys, W. Ulrichts, P. Rocca, F. Guglietta, A. Ayguasanosa, J. |
| author_sort | Knoebl, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429708 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94297082022-08-31 PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES Knoebl, P. de Haard, H. Parys, W. Ulrichts, P. Rocca, F. Guglietta, A. Ayguasanosa, J. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429708/ http://dx.doi.org/10.1097/01.HS9.0000852048.36167.63 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Knoebl, P. de Haard, H. Parys, W. Ulrichts, P. Rocca, F. Guglietta, A. Ayguasanosa, J. PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title | PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title_full | PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title_fullStr | PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title_full_unstemmed | PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title_short | PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES |
| title_sort | pb2305: efgartigimod: clinical development of a novel fcrn antagonist in the treatment of autoimmune diseases |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429708/ http://dx.doi.org/10.1097/01.HS9.0000852048.36167.63 |
| work_keys_str_mv | AT knoeblp pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT dehaardh pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT parysw pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT ulrichtsp pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT roccaf pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT gugliettaa pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases AT ayguasanosaj pb2305efgartigimodclinicaldevelopmentofanovelfcrnantagonistinthetreatmentofautoimmunediseases |